Holen Sie sich die Stockscreener-App
79.51
2.85%
2.20
Vorhandelsmarkt:
79.50
-0.01
-0.01%
Schlusskurs vom Vortag:
$77.31
Offen:
$78.15
24-Stunden-Volumen:
1.88M
Relative Volume:
1.79
Marktkapitalisierung:
$13.79B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
36.81
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
+5.70%
1M Leistung:
+9.11%
6M Leistung:
+6.44%
1J Leistung:
+16.26%
1-Tages-Spanne:
$78.00
$81.64
1-Wochen-Bereich:
$74.68
$81.64
52-Wochen-Spanne:
$60.70
$85.92
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
79.51 | 13.41B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
552.23 | 200.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
189.58 | 54.81B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
75.05 | 37.05B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
243.92 | 35.76B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
257.77 | 18.55B | 2.96B | 487.70M | 344.00M | 6.6758 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum to acquire Acera Surgical - Medical Buyer
How institutional buying supports Solventum Corporation stockWeekly Stock Recap & Growth Focused Entry Point Reports - newser.com
How Solventum Corporation stock behaves in tightening cyclesBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Strategic Acquisition and Capital Management Propel Solventum Corporation’s Growth Potential - TipRanks
Solventum announces $1 billion share repurchase program By Investing.com - Investing.com Nigeria
Solventum stock rises on $1 billion share buyback, Acera acquisition By Investing.com - Investing.com UK
Solventum stock rises on $1 billion share buyback, Acera acquisition - Investing.com
Solventum to Acquire Acera Surgical for $850M - Medical Device and Diagnostic industry
Solventum to acquire soft tissue repair company Acera Surgical, repurchase $1B in shares - MassDevice
Solventum Corporation entered into a definitive agreement to acquire Acera Surgical, Inc. for $850 million. - MarketScreener
Solventum agrees to acquire Acera for up to $850M - BioWorld MedTech
Solventum to Buy Soft Tissue Repair Company Acera Surgical for up to $850M - Medical Product Outsourcing
Solventum to Buy Acera Surgical; Approves $1 Billion Share Repurchase Program - MarketScreener
Why Solventum Corporation Shares Are Climbing - TipRanks
Solventum to acquire Acera Surgical for $725 million - Investing.com
Solventum sets $1 billion share repurchase program - MSN
Solventum To Acquire Privately-held Acera Surgical For Up To $850 Mln - Nasdaq
Solventum to buy private wound care firm Acera (SOLV:NYSE) - Seeking Alpha
Solventum announces agreement to acquire Acera Surgical - MarketScreener
Solventum announces $1 billion share repurchase program - MarketScreener
Solventum to buy Acera Surgical for up to $850 million - MarketScreener
BRIEF-Solventum Announces Agreement To Acquire Acera Surgical - Devdiscourse
Solventum (NYSE: SOLV) to Buy Acera Surgical for $725M Cash Plus $125M Contingent - Stock Titan
Why Solventum Corporation (KB7) stock fits value portfoliosWeekly Trend Summary & Smart Money Movement Alerts - newser.com
Why Solventum Corporation (KB7) stock trades below fair valueTreasury Yields & Real-Time Volume Triggers - newser.com
Can Solventum Corporation (KB7) stock sustain breakout momentum2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-11-19 16:31:11 - newser.com
Why Solventum Corporation stock stays resilientDay Trade & Stepwise Swing Trade Plans - newser.com
Thermo Fisher confirms agreement to buy Solventum filtration unit (update) - MSN
Is Solventum Corporation stock inflation resilientTrade Volume Report & Real-Time Sentiment Analysis - newser.com
Published on: 2025-11-19 01:57:36 - newser.com
Can Solventum Corporation stock attract ESG capital inflows2025 Retail Activity & Free Accurate Trade Setup Notifications - newser.com
How Solventum Corporation stock moves on employment dataDay Trade & Weekly Breakout Watchlists - newser.com
Published on: 2025-11-18 20:20:56 - newser.com
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):